0002052113-26-000458.txt : 20260429 0002052113-26-000458.hdr.sgml : 20260429 20260429160836 ACCESSION NUMBER: 0002052113-26-000458 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20260429 DATE AS OF CHANGE: 20260429 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Eikon Therapeutics, Inc. CENTRAL INDEX KEY: 0001861123 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 842807586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-95483 FILM NUMBER: 26916022 BUSINESS ADDRESS: STREET 1: 230 HARRIET TUBMAN WAY CITY: MILLBRAE STATE: CA ZIP: 94030 BUSINESS PHONE: 341-777-0566 MAIL ADDRESS: STREET 1: 230 HARRIET TUBMAN WAY CITY: MILLBRAE STATE: CA ZIP: 94030 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Portfolio Management LLC CENTRAL INDEX KEY: 0002052113 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (212) 810-5800 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0002052113 XXXXXXXX LIVE Common Stock 03/31/2026 0001861123 Eikon Therapeutics, Inc. 282564103 230 Harriet Tubman Way Millbrae CA 94030 Rule 13d-1(b) BlackRock Portfolio Management LLC b DE 2939120 0 3002737 0 3002737 5.5 HC Eikon Therapeutics, Inc. 230 Harriet Tubman Way Millbrae CA 94030 BlackRock Portfolio Management LLC In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release. BlackRock Portfolio Management LLC, 50 Hudson Yards New York, NY 10001 See Item 4 of Cover Page N HC 3002737 5.5 2939120 0 3002737 0 Y N N Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of Eikon Therapeutics, Inc.. No one person's interest in the common stock of Eikon Therapeutics, Inc. is more than five percent of the total outstanding common shares. N See Exhibit 99 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 24: Power of Attorney Exhibit 99: Item 7 BlackRock Portfolio Management LLC Spencer Fleming 04/29/2026 EX-24 2 PowerOfAttorney.txt EXHIBIT 24: POWER OF ATTORNEY POWER OF ATTORNEY The undersigned, BlackRock Portfolio Management LLC, a limited liability company duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Julie Ashworth, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg, Brenda Schulz and Joseph Virgilio, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries and affiliates, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F, 13H, SHO and N-PX and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 28th day of January, 2025 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 1st day of July, 2025. BLACKROCK PORTFOLIO MANAGEMENT LLC By: BlackRock Finance, Inc., its sole member By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary EX-99 3 Item_7.txt EXHIBIT 99: ITEM 7 Item 7 BlackRock Advisors, LLC BlackRock Investment Management (UK) Limited BlackRock (Luxembourg) S.A. BlackRock Fund Advisors BlackRock Financial Management, Inc. BlackRock Investment Management, LLC *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.